Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis

The Journal of DermatologyEarly View LETTER TO THE EDITOR Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis Yuka Hanami, Corresponding Author Yuka Hanami [email protected] orcid.org/0000-0002-6906-3988 Department of Dermatology, Fukushima Medical University, Fukushima, Japan Correspondence Yuka Hanami, Department of Dermatology, Fukushima Medical University, Fukushima 960-1295, Japan. Email: [email protected]Search for more papers by this authorToshiyuki Yamamoto, Toshiyuki Yamamoto orcid.org/0000-0002-8390-2573 Department of Dermatology, Fukushima Medical University, Fukushima, JapanSearch for more papers by this author Yuka Hanami, Corresponding Author Yuka Hanami [email protected] orcid.org/0000-0002-6906-3988 Department of Dermatology, Fukushima Medical University, Fukushima, Japan Correspondence Yuka Hanami, Department of Dermatology, Fukushima Medical University, Fukushima 960-1295, Japan. Email: [email protected]Search for more papers by this authorToshiyuki Yamamoto, Toshiyuki Yamamoto orcid.org/0000-0002-8390-2573 Department of Dermatology, Fukushima Medical University, Fukushima, JapanSearch for more papers by this author First published: 08 April 2024 https://doi.org/10.1111/1346-8138.17199Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Mustin DE, Cole EF, Blalock TW, Kuruvilla ME, Stoff BK, Feldman RJ. Dupilumab-induced erythema nodosum. JAAD Case Rep. 2022; 19: 41–43. 10.1016/j.jdcr.2021.11.007 PubMedGoogle Scholar 2Llorente L, Richaud-Patin Y, Alvarado C, Reyes E, Alcocer-Varela J, Orozco-Topete R. Elevated Th1 cytokine mRNA in skin biopsies and peripheral circulation in patients with erythema nodosum. Eur Cytokine Netw. 1997; 8: 67–71. CASPubMedWeb of Science®Google Scholar 3Fernandez E, Chandler W, Long PR, Palmer ML, Fadugba O. Dupilumab-associated sweet syndrome. Cutis. 2023; 111: E7–E9. 10.12788/cutis.0798 PubMedGoogle Scholar 4Pérez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, Gomez-Flores M. Erythema nodosum: a practical approach and diagnostic algorithm. Am J Clin Dermatol. 2021; 22: 367–378. 10.1007/s40257-021-00592-w PubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation